scholarly article | Q13442814 |
P50 | author | Chiara Ronchini | Q43734964 |
P2093 | author name string | A J Capobianco | |
C Ronchini | |||
P2860 | cites work | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 |
SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function | Q22253329 | ||
TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms | Q24320364 | ||
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase | Q24554436 | ||
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 | Q24650743 | ||
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition | Q24652527 | ||
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) | Q24685138 | ||
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
The retinoblastoma protein and cell cycle control | Q27860722 | ||
Involvement of Notch1 in the development of mouse mammary tumors | Q28137765 | ||
Notch signaling: from the outside in | Q28139768 | ||
Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5 | Q28140561 | ||
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway | Q28237113 | ||
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain | Q28273268 | ||
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer | Q28285050 | ||
Signalling downstream of activated mammalian Notch | Q28289832 | ||
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
Nuclear access and action of notch in vivo | Q28646384 | ||
Cancer cell cycles | Q29547756 | ||
Stat3 as an oncogene | Q29614606 | ||
D-type cyclin-dependent kinase activity in mammalian cells | Q29614966 | ||
G1 phase progression: cycling on cue | Q29615162 | ||
Induction of S phase by G1 regulatory factors | Q33781902 | ||
Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells | Q33854194 | ||
pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v- | Q33854336 | ||
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway | Q33884776 | ||
Alterations in Notch signaling in neoplastic lesions of the human cervix | Q34124673 | ||
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions | Q34295503 | ||
Function of a human cyclin gene as an oncogene | Q34994859 | ||
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice | Q35114942 | ||
Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle | Q35677993 | ||
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles | Q36366728 | ||
Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit | Q36559825 | ||
Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. | Q36568076 | ||
Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. | Q36573355 | ||
The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions | Q36861078 | ||
A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. | Q36907176 | ||
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts | Q37257805 | ||
Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. | Q37724159 | ||
Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region | Q38320226 | ||
A novel DNA-binding protein, HS2NF5, interacts with a functionally important sequence of the human beta-globin locus control region | Q38350604 | ||
Neoplastic transformation by Notch requires nuclear localization | Q39453336 | ||
Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma | Q39876976 | ||
Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. | Q40022664 | ||
Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms | Q40241821 | ||
Adenovirus-E1A proteins transform cells by sequestering regulatory proteins | Q40823566 | ||
Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation. | Q40860023 | ||
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts | Q40967344 | ||
Mammalian G1 cyclins and cell cycle progression | Q40983870 | ||
Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. | Q41078359 | ||
Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. | Q41426806 | ||
Functional Analysis of the TAN-1 Gene, a Human Homolog of Drosophila Notch | Q41506198 | ||
Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product | Q41522896 | ||
The role of cyclin E in cell proliferation, development and cancer | Q41744187 | ||
Inducible regulatory elements in the human cyclin D1 promoter | Q42498965 | ||
Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation | Q42803654 | ||
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts | Q42807624 | ||
A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice | Q43457473 | ||
The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. | Q47072129 | ||
The suppressor of hairless protein participates in notch receptor signaling | Q47072502 | ||
Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. | Q52539130 | ||
Identity of the beta-globin locus control region binding protein HS2NF5 as the mammalian homolog of the notch-regulated transcription factor suppressor of hairless. | Q52565531 | ||
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. | Q53476711 | ||
Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis | Q59285746 | ||
Cyclin E-induced S phase without activation of the pRb/E2F pathway. | Q60200141 | ||
Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display | Q73174253 | ||
Acute glucose-induced downregulation of PKC-betaII accelerates cultured VSMC proliferation | Q74172709 | ||
Ras pathway signals are required for notch-mediated oncogenesis | Q74298005 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5925-5934 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). | |
P478 | volume | 21 |
Q37131323 | A functional Notch-survivin gene signature in basal breast cancer |
Q35132170 | ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway |
Q79423580 | Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1 |
Q35748204 | Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion |
Q35020680 | Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway |
Q40171511 | Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice |
Q74624551 | Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells |
Q37371156 | Active Notch1 confers a transformed phenotype to primary human melanocytes |
Q34619778 | An invitation to T and more: notch signaling in lymphopoiesis |
Q35949450 | Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. |
Q37013225 | Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment |
Q35102092 | Assembly of a Notch transcriptional activation complex requires multimerization |
Q28200963 | Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch |
Q34329675 | CAMOS, a nonprogressive, autosomal recessive, congenital cerebellar ataxia, is caused by a mutant zinc-finger protein, ZNF592 |
Q41664316 | CSL protein regulates transcription of genes required to prevent catastrophic mitosis in fission yeast. |
Q37598736 | Cancer stem cells: cell culture, markers, and targets for new therapies |
Q35101342 | Cellular target genes of Epstein-Barr virus nuclear antigen 2. |
Q37981219 | Characteristic features of stem cells in glioblastomas: from cellular biology to genetics |
Q28580975 | Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line |
Q33843034 | Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. |
Q38409303 | Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association |
Q41138641 | Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells |
Q35906261 | Cooperation between Wnt and Notch signalling in human breast cancer. |
Q37911375 | Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia |
Q35652417 | Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches |
Q38064316 | Crossing paths in Human Renal Cell Carcinoma (hRCC). |
Q36236802 | Crosstalk between Nrf2 and Notch signaling. |
Q84242761 | Crosstalk of Notch with p53 and p63 in cancer growth control |
Q36249368 | Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms |
Q38035444 | Differential requirements for Wnt and Notch signaling in hematopoietic versus thymic niches |
Q40258375 | Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells |
Q37220068 | Ectopic expression of activated notch or SOX2 reveals similar and unique roles in the development of the sensory cell progenitors in the mammalian inner ear. |
Q42228506 | Effect of mesenchymal stem cells and a novel curcumin derivative on Notch1 signaling in hepatoma cell line. |
Q34948119 | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression |
Q81249003 | ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor |
Q33229068 | Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma |
Q39682930 | Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines |
Q35772118 | Fission Yeast CSL Transcription Factors: Mapping Their Target Genes and Biological Roles |
Q37289384 | Functional redundancy of the Notch pathway in ovarian cancer cell lines |
Q28591740 | Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1 |
Q34811698 | Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling |
Q39560848 | Hes1 is required for contact inhibition of cell proliferation in 3T3-L1 preadipocytes |
Q35309521 | Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity |
Q39227892 | Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells |
Q38742214 | Honokiol inhibits melanoma stem cells by targeting notch signaling |
Q36862089 | Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. |
Q34570988 | Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin |
Q42410840 | Id2a functions to limit Notch pathway activity and thereby influence the transition from proliferation to differentiation of retinoblasts during zebrafish retinogenesis |
Q80313389 | Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program |
Q37085602 | Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer |
Q24309682 | Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors |
Q36376809 | Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia |
Q40403618 | Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells |
Q35642514 | Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds |
Q26776198 | Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features |
Q38827688 | Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5. |
Q37271116 | Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells |
Q34363706 | Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. |
Q38153210 | Interaction of Notch and gp130 signaling in the maintenance of neural stem and progenitor cells |
Q47159829 | Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. |
Q41576456 | Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice |
Q37351155 | Leptin-cytokine crosstalk in breast cancer. |
Q63664803 | Liver regeneration |
Q35256272 | MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. |
Q37308441 | Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies |
Q34301987 | Membrane-bound delta-4 notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potential |
Q35103047 | Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium |
Q37120385 | Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis |
Q44691496 | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. |
Q36711249 | Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways |
Q24323154 | Mutation of the fucose-specific beta1,3 N-acetylglucosaminyltransferase LFNG results in abnormal formation of the spine |
Q38974147 | NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. |
Q35558109 | NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications. |
Q34334437 | NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma |
Q37302750 | New wirings in the survivin networks |
Q38940597 | Non-coding RNAs Functioning in Colorectal Cancer Stem Cells |
Q42800329 | Non-genetic modulation of Notch activity by artificial delivery of Notch intracellular domain into neural stem cells |
Q37802720 | Notch Signaling Pathway as a Therapeutic Target in Breast Cancer |
Q89132880 | Notch Signaling is Required for Dendritic Cell Maturation and T Cell Expansion in Paracoccidioidomycosis |
Q37785199 | Notch Targets and Their Regulation |
Q36917080 | Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. |
Q37527087 | Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression |
Q34233443 | Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice |
Q40592538 | Notch and Schwann cell transformation |
Q39649080 | Notch induces cyclin-D1-dependent proliferation during a specific temporal window of neural differentiation in ES cells. |
Q34330869 | Notch inhibitors for cancer treatment |
Q34707176 | Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia |
Q73614651 | Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis |
Q24675176 | Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells |
Q42028034 | Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. |
Q36804582 | Notch signaling and its integration with other signaling mechanisms. |
Q35551147 | Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents |
Q35838546 | Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction |
Q35622926 | Notch signaling enhances nestin expression in gliomas |
Q37002843 | Notch signaling in differentiation and function of dendritic cells |
Q35858248 | Notch signaling in mammary development and oncogenesis |
Q34491211 | Notch signaling in serous ovarian cancer |
Q37109326 | Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases |
Q41326624 | Notch signaling regulates growth and differentiation in the mammalian lens |
Q26765033 | Notch signaling: its roles and therapeutic potential in hematological malignancies |
Q37169972 | Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition |
Q37867484 | Notch signalling in solid tumours: a little bit of everything but not all the time |
Q28072977 | Notch signalling pathway as an oncogenic factor involved in cancer development |
Q37942597 | Notch signalling pathway in tooth development and adult dental cells |
Q37158058 | Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. |
Q35131413 | Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc |
Q35119038 | Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. |
Q39928689 | Notch1 is an effector of Akt and hypoxia in melanoma development |
Q36402940 | Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation |
Q42473171 | Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors |
Q34506739 | Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. |
Q38324552 | Notching on Cancer's Door: Notch Signaling in Brain Tumors |
Q35889072 | Oncogenesis and cancer stem cells: current opinions and future directions |
Q57050806 | Oncogenic Signaling Induced by HCV Infection |
Q34535041 | PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment. |
Q38352939 | Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis |
Q36530303 | Pocket protein function in melanocyte homeostasis and neoplasia |
Q92366436 | Precision medicine for human cancers with Notch signaling dysregulation (Review) |
Q38226659 | Protein kinases and associated pathways in pluripotent state and lineage differentiation. |
Q83498042 | RETRACTED ARTICLE: Survival of MM cells is dependent on Notch signaling |
Q64095080 | Re-establishing Apoptosis Competence in Bone Associated Cancers via Communicative Reprogramming Induced Through Notch Signaling Inhibition |
Q35578604 | Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands |
Q64109561 | Role of MAML1 in targeted therapy against the esophageal cancer stem cells |
Q37606133 | Role of Notch signaling in colorectal cancer |
Q28505312 | Role of Sox2 in the development of the mouse neocortex |
Q44832250 | Roles for c-Myc in self-renewal of hematopoietic stem cells |
Q35686593 | Shared signaling pathways in normal and breast cancer stem cells |
Q38104238 | Signaling through cyclin D-dependent kinases |
Q90209793 | Structurally conserved binding motifs of transcriptional regulators to notch nuclear effector CSL |
Q36249525 | Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo |
Q35992790 | Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells |
Q28396388 | Sustained proliferation in cancer: Mechanisms and novel therapeutic targets |
Q26771701 | Targeting Notch to overcome radiation resistance |
Q38823095 | Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy |
Q39109832 | Targeting cancer stem cells for chemoprevention of pancreatic cancer. |
Q37696748 | Targeting notch signaling pathway in cancer: clinical development advances and challenges |
Q26863580 | Targeting the Notch signaling pathway in cancer therapeutics |
Q38359402 | The C-terminal PDZ-ligand of JAGGED1 is essential for cellular transformation |
Q90592035 | The Caenorhabditis elegans homolog of the Evi1 proto-oncogene, egl-43, coordinates G1 cell cycle arrest with pro-invasive gene expression during anchor cell invasion |
Q64983506 | The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells. |
Q36615348 | The Notch pathway in ovarian carcinomas and adenomas. |
Q36971953 | The Notch signaling pathway as a mediator of tumor survival |
Q36302942 | The bHLH Transcription Factor NeuroD Governs Photoreceptor Genesis and Regeneration Through Delta-Notch Signaling |
Q36002446 | The elements of human cyclin D1 promoter and regulation involved |
Q34132722 | The functional role of Notch signaling in human gliomas |
Q37303838 | The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group |
Q33566723 | The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets |
Q53227690 | The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase. |
Q35920751 | The intracellular form of notch blocks transforming growth factor beta-mediated growth arrest in Mv1Lu epithelial cells |
Q36970638 | The many faces of Notch signaling in skin-derived cells |
Q38315114 | The opposing roles of NOTCH signalling in head and neck cancer: a mini review |
Q29620694 | The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation |
Q41593423 | The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets |
Q37256444 | The role of Notch signaling in human cervical cancer: implications for solid tumors |
Q38347118 | Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. |
Q37081884 | Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model |
Q38221361 | Wnt-Notch signalling crosstalk in development and disease. |
Q36347670 | Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein |
Q42045150 | Wnt5a is a crucial regulator of neurogenesis during cerebellum development |
Q27023599 | Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer |
Q39686487 | XPak3 promotes cell cycle withdrawal during primary neurogenesis in Xenopus laevis |
Q34958884 | c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma |
Q40336111 | c-Myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes |
Q39894711 | gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity |
Q35962323 | miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. |
Q40584271 | p53 regulates thymic Notch1 activation |
Q64063739 | ≤ Cyclin D1 protein affecting global women's health by regulating HPV mediated adenocarcinoma of the uterine cervix |
Search more.